These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

530 related articles for article (PubMed ID: 28583135)

  • 1. Outcomes and prognostic factors of non-HIV patients with pneumocystis jirovecii pneumonia and pulmonary CMV co-infection: A Retrospective Cohort Study.
    Yu Q; Jia P; Su L; Zhao H; Que C
    BMC Infect Dis; 2017 Jun; 17(1):392. PubMed ID: 28583135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytomegaloviral or
    Sun YS; Huang DF; Lin FC; Hsu CK; Sun IT; Chang SC; Tsai CY; Lai CC
    J Rheumatol; 2019 Mar; 46(3):251-258. PubMed ID: 30504509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors associated with Pneumocystis jirovecii pneumonia in non-HIV immunocompromised patients and co-pathogens analysis by metagenomic next-generation sequencing.
    Huang L; Xu S; Huang Z; Chen Y; Xu N; Xie B
    BMC Pulm Med; 2023 Feb; 23(1):72. PubMed ID: 36829171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association between Cytomegalovirus co-infection with Pneumocystis pneumonia and mortality in immunocompromised non-HIV patients.
    Korkmaz Ekren P; Töreyin ZN; Nahid P; Doskaya M; Caner A; Turgay N; Zeytinoglu A; Toz S; Bacakoglu F; Guruz Y; Erensoy S
    Clin Respir J; 2018 Nov; 12(11):2590-2597. PubMed ID: 30244544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of cytomegalovirus and cell-mediated immunity for predicting outcomes in non-HIV-infected patients with Pneumocystis jirovecii pneumonia.
    Kim T; Park SY; Lee HJ; Kim SM; Sung H; Chong YP; Lee SO; Choi SH; Kim YS; Woo JH; Kim SH
    Medicine (Baltimore); 2017 Jul; 96(30):e7243. PubMed ID: 28746178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human herpes virus co-infection is associated with mortality in HIV-negative patients with Pneumocystis jirovecii pneumonia.
    Fillatre P; Chevrier S; Revest M; Gacouin A; Jouneau S; Leroy H; Robert-Gangneux F; Minjolle S; Le Tulzo Y; Tattevin P
    Eur J Clin Microbiol Infect Dis; 2013 Feb; 32(2):189-94. PubMed ID: 22930407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of cytomegalovirus infection on clinical severity and outcomes in kidney transplant recipients with Pneumocystis jirovecii pneumonia.
    Lee S; Park Y; Kim SG; Ko EJ; Chung BH; Yang CW
    Microbiol Immunol; 2020 May; 64(5):356-365. PubMed ID: 31994768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of concomitant pulmonary infection on immune dysregulation in Pneumocystis jirovecii pneumonia.
    Chou CW; Lin FC; Tsai HC; Chang SC
    BMC Pulm Med; 2014 Nov; 14():182. PubMed ID: 25409888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of non-HIV-infected patients with Pneumocystis pneumonia and concomitant pulmonary cytomegalovirus infection.
    Kim T; Moon SM; Sung H; Kim MN; Kim SH; Choi SH; Jeong JY; Woo JH; Kim YS; Lee SO
    Scand J Infect Dis; 2012 Sep; 44(9):670-7. PubMed ID: 22264016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the performance of DiaSorin molecular Pneumocystis jirovecii-CMV multiplex real-time PCR assay from bronchoalveolar lavage samples.
    Kilic A; Elliott S; Hester L; Palavecino E
    J Mycol Med; 2020 Jun; 30(2):100936. PubMed ID: 32044156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary co-infections by Pneumocystis jirovecii and Aspergillus fumigatus in non-HIV patients: A report of two cases and literature review.
    Markantonatou AM; Ioakimidou A; Arvaniti K; Manou E; Papadopoulos V; Kiriklidou P; Samaras K; Kioumi A; Vyzantiadis TA
    Mycoses; 2017 Oct; 60(10):626-633. PubMed ID: 28660636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-infection of Pneumocystis jirovecii pneumonia and pulmonary CMV in a infant with X-linked severe combined immunodeficiency.
    Cheng L; Liu K; Luo X; Mao X; Chen Y; Cao K
    Diagn Cytopathol; 2021 Sep; 49(9):E340-E343. PubMed ID: 33929775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Veno-Venous Extracorporeal Membrane Oxygenation for Severe Pneumocystis jirovecii Pneumonia in an Immunocompromised Patient without HIV Infection.
    Nureki SI; Usagawa Y; Watanabe E; Takenaka R; Shigemitsu O; Abe T; Yasuda N; Goto K; Kitano T; Kadota JI
    Tohoku J Exp Med; 2020 Apr; 250(4):215-221. PubMed ID: 32249237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of crazy paving ground grass opacities in non-HIV Pneumocystis jirovecii pneumonia: an observational cohort study.
    Kumagai S; Arita M; Koyama T; Kumazawa T; Inoue D; Nakagawa A; Kaji Y; Furuta K; Fukui M; Tomii K; Taguchi Y; Tomioka H; Ishida T
    BMC Pulm Med; 2019 Feb; 19(1):47. PubMed ID: 30791907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pneumocystis jirovecii Pneumonia in the Non-HIV-Infected Population.
    Avino LJ; Naylor SM; Roecker AM
    Ann Pharmacother; 2016 Aug; 50(8):673-9. PubMed ID: 27242349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between cytomegalovirus retrieved by bronchoalveolar lavage and mortality in patients with HIV.
    Hayner CE; Baughman RP; Linnemann CC; Dohn MN
    Chest; 1995 Mar; 107(3):735-40. PubMed ID: 7874946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pneumocystis jirovecii pneumonia in children. A retrospective study in a single center over three decades.
    García-Moreno J; Melendo-Pérez S; Martín-Gómez MT; Frick MA; Balcells-Ramírez J; Pujol-Jover M; Martín-Nalda A; Mendoza-Palomar N; Soler-Palacín P
    Enferm Infecc Microbiol Clin (Engl Ed); 2020 Mar; 38(3):111-118. PubMed ID: 31272810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pneumocystis jiroveci pneumonia in immunocompromised patients: delayed diagnosis and poor outcomes in non-HIV-infected individuals.
    Li MC; Lee NY; Lee CC; Lee HC; Chang CM; Ko WC
    J Microbiol Immunol Infect; 2014 Feb; 47(1):42-7. PubMed ID: 23063081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pneumocystis jiroveci pneumonia in Taiwan from 2014 to 2017: Clinical manifestations and outcomes between pediatric and adult patients.
    Lee HY; Lu CY; Lee PI; Chen JM; Huang LM; Chang LY
    J Microbiol Immunol Infect; 2019 Dec; 52(6):983-990. PubMed ID: 31164278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pneumocystis jirovecii pneumonia in mycophenolate mofetil-treated patients with connective tissue disease: analysis of 17 cases.
    Zhang Y; Zheng Y
    Rheumatol Int; 2014 Dec; 34(12):1765-71. PubMed ID: 24948376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.